
EXACT Therapeutics is a clinical stage Norwegian biotech company developing a technology platform for targeted therapeutic enhancement – Acoustic Cluster Therapy (ACT®). ACT®sonoporation is a unique approach to ultrasound-mediated, targeted drug enhancement – with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.

Biotechnology

EXACT Therapeutics

Per Walday

Caspar Foghsgaard

Danishad Appu

John M. Edminson

Morten Smedsrud Wigen

Hilary Mcelwaine-Johnn

Ragnar Bendiksen

Melina Mühlenpfordt

Amir Snapir

Svein Kvåle

The current leadership team at EXACT Therapeutics has a wealth of experience in the finance industry, with members having worked as a Chief Financial Officer at Interim, EXACT-Tx AS, and Autolus Therapeutics plc, as well as VP Finance at The Whiteley Clinic Ltd. All members of the team have been educated to a high level, with the team holding degrees from The London School of Economics and Political Science (LSE) in Economics.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at EXACT Therapeutics

Board of Directors

CEO and Executive Team